Exogenous Ketones and Behavior

NCT ID: NCT06515717

Last Updated: 2024-07-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-18

Study Completion Date

2025-06-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will examine the effect of exogenous ketone ester on behavior and metabolism using Virtual Reality and computerizes behavioral tasks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study investigates the effects of exogenous ketone ester on behavior, cognition, and metabolism over one week of consumption. Using a within-subjects, randomized, crossover design, participants will undergo two phases: one with the ketone ester supplement and one with a calorie- and taste-matched placebo. The study includes four lab visits: visits 1 and 3 mark the first day of each intervention, while visits 2 and 4 mark the last day. During each visit, participants will complete behavioral tasks, questionnaires, and blood tests. Additionally, participants will record their food intake via an app and collect stool samples throughout the intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ketone ester

Participants consume a ketone ester 3x per day for 8 days.

Group Type EXPERIMENTAL

ketone ester

Intervention Type DIETARY_SUPPLEMENT

oral supplement

Placebo containing dextrose

Participants consume a placebo 3x per day for 8 days. The placebo is matched in calories and taste to the ketone ester.

Group Type PLACEBO_COMPARATOR

dextrose (placebo)

Intervention Type DIETARY_SUPPLEMENT

oral supplement calorie and taste matched to ketone supplement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ketone ester

oral supplement

Intervention Type DIETARY_SUPPLEMENT

dextrose (placebo)

oral supplement calorie and taste matched to ketone supplement

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Consent to participate
* Fluent in German
* Physically healthy. No regular medication
* No drug use 1 week prior to the study
* BMI 18-31 kg/m2

Exclusion Criteria

* Former or current illnesses of:
* Brain or mind (including eating disorders, personality disorders, alcohol, drugs or drug dependence, neurological disorders other than occasional headache; depression or anxiety disorder excluded)
* Heart or blood circulation
* Gastro-intestinal or endocrine disorders
* Liver or kidney disorders
* Electrolyte imbalance
* Other serious past or present medical conditions (for example, metabolic syndrome, diabetes, cancer)
* Pregnancy
* Extreme athletes (\>2h/day intense work-out; casual cycling or walking is ok)
* Menopause (post menopause is ok)
* Ketogenic diet, ketogenic supplement intake, intermittent fasting or calorie restricted diet during preceding 4 weeks of study participation
* Fear of blood draw
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

German Institute of Human Nutrition

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Dr. Soyoung Q Park

Prof. Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

German Institute of Human Nutrition

Potsdam, Brandenburg, Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Beatrix Keweloh

Role: CONTACT

+49 33200 882518

Soyoung Q Park, Prof.

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Bianca Weigel

Role: primary

+49 33200 882724

References

Explore related publications, articles, or registry entries linked to this study.

Eisenstein SA, Gredysa DM, Antenor-Dorsey JA, Green L, Arbelaez AM, Koller JM, Black KJ, Perlmutter JS, Moerlein SM, Hershey T. Correction: Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity. PLoS One. 2016 Jan 8;11(1):e0147063. doi: 10.1371/journal.pone.0147063. eCollection 2016. No abstract available.

Reference Type BACKGROUND
PMID: 26744894 (View on PubMed)

Goette L, Bendahan S, Thoresen J, Hollis F, Sandi C. Stress pulls us apart: anxiety leads to differences in competitive confidence under stress. Psychoneuroendocrinology. 2015 Apr;54:115-23. doi: 10.1016/j.psyneuen.2015.01.019. Epub 2015 Feb 19.

Reference Type BACKGROUND
PMID: 25705012 (View on PubMed)

Liu L, Artigas SO, Ulrich A, Tardu J, Mohr PNC, Wilms B, Koletzko B, Schmid SM, Park SQ. Eating to dare - Nutrition impacts human risky decision and related brain function. Neuroimage. 2021 Jun;233:117951. doi: 10.1016/j.neuroimage.2021.117951. Epub 2021 Mar 12.

Reference Type BACKGROUND
PMID: 33722669 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ExoKet

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Variations in Ketone Metabolism
NCT05924295 RECRUITING NA
Hemodynamic Effects of Chronic Ketosis.
NCT05161650 COMPLETED PHASE2